6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M

6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...

6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)

6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...

6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...

6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...

6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification

6/3/2022Patient Activeness During Online Medical Consultation in China: Multil...

6/2/2022NMPA Solicits Comments on the Draft Good Manufacturing Practices for D...

6/2/2022China to Initiate Nationwide Unannounced BMI Fund Inspection

6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development

6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors

5/31/2022Recent Executive Moves

5/30/2022SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)

5/27/2022NMPA Issues Chinese GMP's Clinical Trial Drug Appendix

5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...

5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021

5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...

5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)

5/25/2022Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China

5/25/2022State Council Issues Notice on Major Tasks for Deepening Healthcare Re...

5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement

5/24/2022ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...

5/24/2022CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...

5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...

5/23/2022Novartis's Promacta Approved in China for Expanded Use in Children Ag...

5/23/2022Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022

5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021

5/23/2022VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...

5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers

Page:43/333 Total number of articles:9989: [First][<<] [41] [42] [43] [44] [45] [>>] [End]